About Applied Therapeutics
Applied Therapeutics is a company based in New York (United States) founded in 2015 was acquired by Cycle Pharma in December 2025. Applied Therapeutics has raised $65.16 million across 7 funding rounds from investors including ARE, Cycle Pharma and Syno Capital. The company has 35 employees as of December 31, 2024. Applied Therapeutics offers products and services including Govorestat and AT-001. Applied Therapeutics operates in a competitive market with competitors including Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others.
- Headquarter New York, United States
- Employees 35 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Applied Therapeutics, Inc.
-
Annual Revenue
$455 K (USD)-95.45as on Dec 31, 2024
-
Net Profit
-$105.62 M (USD)11.81as on Dec 31, 2024
-
EBITDA
-$103.87 M (USD)-61.84as on Dec 31, 2024
-
Total Equity Funding
$65.16 M (USD)
in 7 rounds
-
Latest Funding Round
$100 M (USD), Post-IPO
Feb 27, 2024
-
Investors
ARE
& 4 more
-
Employee Count
35
as on Dec 31, 2024
-
Acquired by
Cycle Pharma
(Dec 11, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Applied Therapeutics
Applied Therapeutics is a publicly listed company on the NASDAQ with ticker symbol APLT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Applied Therapeutics
Applied Therapeutics offers a comprehensive portfolio of products and services, including Govorestat and AT-001.
Drug targeting rare metabolic disorders for patient treatment.
Potential therapy for rare conditions in clinical development.
People of Applied Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of Applied Therapeutics
Applied Therapeutics has successfully raised a total of $65.16M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $100 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $100.0M
-
First Round
First Round
(08 Feb 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Post-IPO - Applied Therapeutics | Valuation |
investors |
|
| May, 2023 | Amount | Post-IPO - Applied Therapeutics | Valuation |
investors |
|
| Nov, 2019 | Amount | Post-IPO - Applied Therapeutics | Valuation |
investors |
|
Investors in Applied Therapeutics
Applied Therapeutics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Cycle Pharma and Syno Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Syno Capital is focused on healthcare investment and innovation.
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by E Squared Capital.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Applied Therapeutics
Financial Statements - Applied Therapeutics
Applied Therapeutics Comparisons
Competitors of Applied Therapeutics
Applied Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Therapeutics for heart and cardiovascular diseases are developed.
|
Frequently Asked Questions about Applied Therapeutics
Applied Therapeutics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Applied Therapeutics is headquartered in New York, United States. It is registered at New York, New York, United States.
Applied Therapeutics is a funded company, having raised a total of $65.16M across 7 funding rounds to date. The company's 1st funding round was a Post-IPO of $20.01M, raised on Feb 08, 2017.
As of Dec 31, 2024, the latest employee count at Applied Therapeutics is 35.
Annual revenue of Applied Therapeutics is $455K as on Dec 31, 2024.
Applied Therapeutics was founded in 2015 and is headquartered in New York, United States. Focus is placed on the development of novel drugs targeting metabolic and cardiovascular diseases within the biotechnology sector. Proprietary technology, licensed from Dr. Donald Landrys laboratory at Columbia University, is applied to enzymes previously linked to these conditions but unsuccessful in prior therapies. Operations center on advancing these targets toward clinical applications.
Applied Therapeutics's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.
Applied Therapeutics offers Govorestat and AT-001.
Yes, Applied Therapeutics is publicly traded on NASDAQ under the ticker symbol APLT.
Applied Therapeutics has 5 investors. Key investors include ARE, Cycle Pharma, Syno Capital, E Squared Capital, and ETP Global Fund.
The ticker symbol of Applied Therapeutics is APLT on NASDAQ.